David Martin Swope

Title(s)Health Sciences Professor, Neurology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-3703
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders. Front Immunol. 2023; 14:1297340. Rajmohan R, Baveja S, Nguyen D, Shah E, Sy M, Attaripour S, Swope D. PMID: 38259445; PMCID: PMC10800536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Aceruloplasminemia and putaminal cavitation. Parkinsonism Relat Disord. 2018 06; 51:121-123. Riboldi GM, Anstett K, Jain R, Lau H, Swope D. PMID: 29534945.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    3. Early Use of 60 Hz Frequency Subthalamic Stimulation in Parkinson's Disease: A Case Series and Review. Neuromodulation. 2015 Dec; 18(8):664-9. Ramdhani RA, Patel A, Swope D, Kopell BH. PMID: 25833008.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    4. Diffusion of botulinum toxins. Tremor Other Hyperkinet Mov (N Y). 2012; 2. Brodsky MA, Swope DM, Grimes D. PMID: 23440162; PMCID: PMC3570036.
      View in: PubMed   Mentions: 21     Fields:    
    5. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther. 2012 Jul; 34(7):1487-504. Chen JJ, Ondo WG, Dashtipour K, Swope DM. PMID: 22749259.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimals
    6. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease. Pharmacotherapy. 2009 Dec; 29(12):1452-67. Chen JJ, Swope DM, Dashtipour K, Lyons KE. PMID: 19947805.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    7. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurol Clin. 2008 May; 26 Suppl 1:54-65. Swope D, Barbano R. PMID: 18603168.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    8. Pharmacotherapy for Parkinson's disease. Pharmacotherapy. 2007 Dec; 27(12 Pt 2):161S-173S. Chen JJ, Swope DM. PMID: 18041936.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    9. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Clin Ther. 2007 Sep; 29(9):1825-49. Chen JJ, Swope DM, Dashtipour K. PMID: 18035186.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    10. Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease. Pharmacotherapy. 2006 Jun; 26(6):840-52. Obering CD, Chen JJ, Swope DM. PMID: 16716137.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    11. Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease. J Clin Pharmacol. 2005 Aug; 45(8):878-94. Chen JJ, Swope DM. PMID: 16027398.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    12. A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A. J Clin Psychiatry. 2005 Feb; 66(2):267-8. Chen JJ, Swope DM. PMID: 15705018.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Rapid treatment of "wearing off" in Parkinson's disease. Neurology. 2004 Mar 23; 62(6 Suppl 4):S27-31. Swope DM. PMID: 15037669.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Essential tremor: diagnosis and treatment. Pharmacotherapy. 2003 Sep; 23(9):1105-22. Chen JJ, Swope DM. PMID: 14524643.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    15. Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord. 2000 Nov; 15(6):1242-7. Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF. PMID: 11104213.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    16. Subthalamic stimulation in Parkinson's disease. Preliminary results. Stereotact Funct Neurosurg. 1999; 72(2-4):170-3. Lévesque MF, Taylor S, Rogers R, Le MT, Swope D. PMID: 10853073.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    David's Networks
    Concepts (88)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _